BCM
MDT icon

BlueCrest Capital Management’s Medtronic MDT Stock Holding History

BlueCrest Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,500
Closed -$3.02M – 244
2023
Q3 		$3.02M Buy
+38,500
New +$3.22M 0.13% 105

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlueCrest Capital Management's MDT Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 11,450 shares — an estimated $943K sold.

BlueCrest Capital Management first reported a position in MDT in Q3 2014 and held it in 11 quarters. The position peaked at $10M in Q3 2017. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 11,450 Medtronic shares in Q1 2024, an estimated $943K.
  • BlueCrest Capital Management first reported a position in Medtronic in Q3 2014 and held it in 11 quarters.
  • BlueCrest Capital Management's Medtronic position peaked at $10M in Q3 2017.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.